Alcon (SIX/NYSE:ALC) reported fourth-quarter revenues that beat the consensus of Wall Street analysts, with earnings in-line with expectations. The Geneva-based eye care tech company yesterday evening also released 2023 guidance that was ahead of The Street’s consensus. However, Alcon’s actual Q4 results showed slowing sales growth as the company swung to a loss. Alcon lost […]
Alcon
Alcon to pay $199M to J&J to settle patent dispute
Alcon (SIX/NYSE: ALC) recently announced that it has settled a patent dispute with J&J Surgical Vision. The $199 million settlement, announced Feb. 12, ends a lawsuit that J&J had filed in June 2020 in U.S. District Court in Delaware. J&J Surgical Vision had claimed that Alcon femtosecond laser-assisted cataract surgery devices, including the company’s LenSx […]
Alcon to soon launch reusable lens for astigmatism
Alcon (NYSE:ALC) announced today that it plans to launch its Total30 reusable contact lens for people with astigmatism. Geneva, Switzerland-based Alcon designed Total30 with its proprietary water gradient material. This enables a gradual increase to nearly 100% water on the outermost surface. With this technology, the lens ensures that nothing touches the eye but a […]
Alcon stock rises on Q3 EPS beat
Alcon (NYSE:ALC) shares ticked up this morning on third-quarter results that came in ahead of the consensus earnings forecast. Shares of ALC were up more than 4% at $66.47 apiece by early afternoon trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up more than […]
5 top ophthalmic device innovations you need to know
Innovation finds its way into all areas of medtech, and ophthalmic treatments represent another burgeoning space. It may not be a new wave, but medtech companies continue to improve upon technologies for the human eye. Implants, lenses and more comprise the space’s latest innovations, with a number of companies finding new ways to fix old […]
Alcon lowers its 2022 forecast amid strong dollar
Alcon (SIX/NYSE:ALC) posted Street-beating second quarter results but lowered its 2022 guidance amid a challenging macroeconomic environment. The Geneva-based eye care tech giant announced yesterday evening that it earned $148 million, or 30¢ per share, off $2.22 billion in sales during the quarter ended June 30, 2022, for a bottom-line decline of 2% and a […]
Alcon to pay $60M to acquire Kala Pharmaceuticals’ dry eye treatment
Alcon (NYSE:ACL) announced today that it agreed to acquire Eysuvis pharmaceutical eye drops from Kala Pharmaceuticals. Geneva, Switzerland-based Alcon will pay $60 million upfront to Kala for the dry eye treatment. As part of the agreement, the company will also acquire Kala’s Inveltys corticosteroid for twice-per-day treatment of post-operative inflammation and pain following ocular surgery. Get the […]
Alcon beats the Street with Q1 results
Alcon (SIX/NYSE:ALC) posted first quarter results today that beat the consensus forecast on Wall Street and maintained its sales and earnings outlook for the rest of the year. The Geneva, Switzerland–based eye care tech company reported profits of $168 million, or $0.34 per share, on sales of $2.2 billion for the three months ended March […]
18 of the world’s most innovative medical technologies
Judges this week are voting for the most innovative medical technologies among the nominees for the 2022 Prix Galien International Awards. The Prix Galien International Awards highlight the most innovative technologies in the life sciences industry. The New York-based Galien Foundation presents the international award to eligible nominees that have received a Prix Galien award […]
Alcon SmartCataract study shows enhanced time savings during cataract surgery
Alcon (NYSE:ALC) announced data from a clinical study supporting the use of its SmartCataract solutions for cataract surgery. Geneva, Switzerland-based Alcon will present the data at this year’s American Society of Cataract and Refractive Surgery (ASCRS) meeting. According to a news release, Alcon’s latest data for the SmartCataract demonstrates significant time savings delivered during the […]
Alcon launches new dry eye treatment device
Alcon announced that it introduced the Systane iLux meibomian gland dysfunction (MGD) thermal pulsation system. Geneva, Switzerland-based Alcon designed the all-in-one, handheld Systane iLux MGD thermal pulsation device with new imaging technology to capture infrared photos and HD video of the meibomian glands. The system allows patients to see the need for treatment, visualize their […]
